Cancer

ethnically diverse senior men being active
June 18, 2015

Vanderbilt-led study finds significant drop in new prostate cancer diagnoses

A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force against routine PSA screening for men.

By VUMC News and Communications
June 11, 2015

Lung cancer foundation lauds Massion’s contributions

Pierre Massion, M.D., director of the Thoracic Program and an Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has been recognized for his pioneering work in lung cancer by the LUNGevity Foundation.

By VUMC News and Communications
May 18, 2015

Tools for exploring ‘omics’ data

The NetGestalt computing portal integrates vast amounts of data to aid users in finding biologically and clinically relevant information.

By Leigh MacMillan
April 30, 2015

Photo: Cancer screening

Vanderbilt University Medical Center physicians recently provided free cancer screenings for 116 patients at the Odess Head and Neck Cancer Surgery Clinic and the Veterans Affairs Tennessee Valley Healthcare System.

By VUMC News and Communications
kidney x-ray
April 16, 2015

Study shows statin use improves renal cell cancer survival

A new study led by Vanderbilt University investigators found that patients being treated with statins at the time of surgery for kidney cancer, also known as renal cell carcinoma, had improved overall survival and disease-specific survival.

By VUMC News and Communications
April 9, 2015

Free screening event for head and neck cancer set for April 17

Of every 100 people in the United States, at least three men or women will be diagnosed with head and neck cancer in their lifetimes. These cancers can occur in the nasal cavity, sinuses, throat, lips, mouth, thyroid, salivary glands or the voice box (larynx).

By VUMC News and Communications
April 8, 2015

Micelle “packets” deliver cancer drugs

Vanderbilt researchers designed micelle “packets” to selectively deliver anti-cancer drugs to breast cancer cells.
By VUMC News and Communications
April 2, 2015

Study explores driver behind lung cancer tumor progression

Vanderbilt-Ingram Cancer Center investigators have identified the mechanisms used by a gene and its binding protein to drive tumor growth in several forms of cancer, including non-small cell lung cancer.
By VUMC News and Communications
March 12, 2015

VUMC’s Barocas named to Commission on Cancer

Daniel Barocas, M.D., MPH, assistant professor of Urologic Surgery at Vanderbilt University Medical Center, was recently named a representative on the Commission on Cancer.
By VUMC News and Communications
March 12, 2015

Gene mutations may predict melanoma response to immunotherapies

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators.
By VUMC News and Communications
March 5, 2015

Moses, Shyr named to Institute of Medicine cancer therapies panel

Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies.
By VUMC News and Communications
February 9, 2015

Gene profile predicts metastasis

A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found.
By Yan Su
February 5, 2015

Grant bolsters Kirschner’s prostate cancer research

Austin Kirschner, M.D., Ph.D., assistant professor of Radiation Oncology and Cancer Biology, has received the Urology Care Foundation Research Scholars Award for the study of advanced prostate cancer.
By VUMC News and Communications